Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Holdings Increased by Premier Fund Managers Ltd

Premier Fund Managers Ltd lifted its position in Alpha Teknova, Inc. (NASDAQ:TKNO) by 92.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 192,744 shares of the company’s stock after acquiring an additional 92,744 shares during the period. Premier Fund Managers Ltd’s holdings in Alpha Teknova were worth $4,723,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in TKNO. Russell Investments Group Ltd. purchased a new position in shares of Alpha Teknova in the second quarter worth approximately $396,000. BlackRock Inc. purchased a new position in Alpha Teknova during the second quarter valued at approximately $4,027,000. Monashee Investment Management LLC purchased a new position in Alpha Teknova during the second quarter valued at approximately $2,017,000. Vanguard Group Inc. purchased a new position in Alpha Teknova during the second quarter valued at approximately $1,424,000. Finally, Franklin Resources Inc. purchased a new position in Alpha Teknova during the second quarter valued at approximately $5,933,000. 25.54% of the stock is currently owned by institutional investors and hedge funds.

NASDAQ TKNO opened at $16.31 on Friday. The company has a current ratio of 17.90, a quick ratio of 17.19 and a debt-to-equity ratio of 0.08. The company has a 50 day moving average price of $20.37 and a two-hundred day moving average price of $21.54. Alpha Teknova, Inc. has a 12-month low of $15.00 and a 12-month high of $30.89.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Tuesday, November 9th. The company reported ($0.12) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.12). The firm had revenue of $9.39 million during the quarter, compared to analyst estimates of $8.00 million. As a group, analysts anticipate that Alpha Teknova, Inc. will post -0.41 EPS for the current fiscal year.

TKNO has been the topic of a number of research analyst reports. Cowen boosted their price objective on shares of Alpha Teknova from $24.00 to $30.00 and gave the company an “outperform” rating in a research report on Thursday, October 14th. Zacks Investment Research cut shares of Alpha Teknova from a “hold” rating to a “sell” rating in a research note on Wednesday, December 8th. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. According to MarketBeat.com, Alpha Teknova has an average rating of “Buy” and an average price target of $27.67.

Alpha Teknova Profile

Alpha Teknova, Inc provides reagents for bioprocessing, bioproduction, and molecular diagnostics. The company's reagents enable the discovery, research, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. It offers liquid culture, dry culture, agar, and animal-free media, as well as pre-poured plates, biological buffers, solutions, chemicals, and various treated and certified waters.

Featured Story: What is the LIBOR?

Want to see what other hedge funds are holding TKNO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alpha Teknova, Inc. (NASDAQ:TKNO).

Institutional Ownership by Quarter for Alpha Teknova (NASDAQ:TKNO)

Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.